1.49
Adc Therapeutics Sa (ADCT) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
7.69%
19.25
|
20.85 | 23.06 | 16.43 | 18.84 |
| Research and Development |
12.63%
17.37
|
19.88 | - | - | - |
| Costs And Expenses |
3.11%
44.66
|
46.10 | 40.98 | 47.40 | 62.99 |
| Operating Income/Loss |
0.67%
-25.41
|
-25.25 | -17.92 | -30.97 | -44.15 |
| Nonoperating Income/Loss |
214.58%
8.849
|
-7.723 | 11.11 | -9.997 | -11.24 |
| Income/Loss From Continuing Operations Before Tax |
49.75%
-16.57
|
-32.97 | -6.813 | -40.97 | -55.39 |
| Income Tax Expense/Benefit |
-
|
- | -0.404 | - | 1.254 |
| Net Income/Loss |
49.75%
-16.57
|
-32.97 | -6.409 | -40.97 | -56.65 |
| Basic Average Shares |
0.57%
155.02
|
154.14 | 7.8297 | 136.45 | 113.74 |
| Diluted Average Shares |
0.57%
155.02
|
154.14 | 7.8297 | 136.45 | 113.74 |
| Basic Earnings Per Share |
47.62%
-0.11
|
-0.21 | 0.02 | -0.30 | -0.50 |
| Diluted Earnings Per Share |
47.62%
-0.11
|
-0.21 | 0.02 | -0.30 | -0.50 |
大文字化:
|
ボリューム (24 時間):